All three participants stated they were more likely to adhere to prescribed regimens if they had a strong relationship with their provider. Also, they place a premium on patient-centered care. c. While all patients have used pharmacologic treatments, they noted various concerns with statins. In addition, they had a general preference for reducing their CV risk via non-pharmacologic treatments. All three participants generally did not experience issues regarding adherence to statins. However, some did struggle to take it at the proper time of day. Statin side effects varied for the three participants. One participant never had side effects. One participant experienced side effects, but the benefits outweighed the harms. Comparatively, two participants stopped taking statins because of side effects. All three participants had tried multiple statins and changed their course of treatment to reduce side effects. d. Patients had health concerns in addition to their cholesterol and stressed the importance that providers consider comorbidities when managing their cholesterol. Two participants are primarily concerned with cholesterol levels and heart health, while another was more concerned with chronic conditions or other diseases posing more immediate barriers to their life. Whether dyslipidemia was a patient s primary health care concern depended on their risk levels, comorbidities, and family history. e. Patients generally find mobile apps and smart devices useful for monitoring their health. Even though not all patients prefer telemedicine and other technology options, providers should be ready to offer these options. All three participants use devices (e.g., smartphone, smartwatch) for monitoring their health and some use this modality to share health information with providers. One participant communicated with a remote private provider via Skype and enjoys using this method of communication. 